MLSS Quote, Financials, Valuation and Earnings

Envista Holdings Corp. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of -4.52%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Envista Holdings Corp.'s return on equity of 0.5%.

Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 240.25%. On the other hand Envista Holdings Corp. has an analysts' consensus of $22.38 which suggests that it could fall by -5.27%. Given that Milestone Scientific, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Milestone Scientific, Inc. is more attractive than Envista Holdings Corp..

Milestone Scientific, Inc. has a beta of 0.891, which suggesting that the stock is 10.933% less volatile than S&P 500. In comparison Envista Holdings Corp. has a beta of 0.993, suggesting its less volatile than the S&P 500 by 0.684%.

Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Envista Holdings Corp. pays out -- of its earnings as a dividend.

Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Envista Holdings Corp. quarterly revenues of $669.9M. Milestone Scientific, Inc.'s net income of -$1.2M is higher than Envista Holdings Corp.'s net income of -$30.3M. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Envista Holdings Corp.'s PE ratio is 282.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 2.67x versus 1.54x for Envista Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Solventum Corp. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of 60.4%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Solventum Corp.'s return on equity of 42.2%.

Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 240.25%. On the other hand Solventum Corp. has an analysts' consensus of $87.18 which suggests that it could grow by 1.21%. Given that Milestone Scientific, Inc. has higher upside potential than Solventum Corp., analysts believe Milestone Scientific, Inc. is more attractive than Solventum Corp..

Milestone Scientific, Inc. has a beta of 0.891, which suggesting that the stock is 10.933% less volatile than S&P 500. In comparison Solventum Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Solventum Corp. pays out -- of its earnings as a dividend.

Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Solventum Corp. quarterly revenues of $2.1B. Milestone Scientific, Inc.'s net income of -$1.2M is lower than Solventum Corp.'s net income of $1.3B. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Solventum Corp.'s PE ratio is 9.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 2.67x versus 1.79x for Solventum Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona, Inc. has a net margin of -48.9% compared to Milestone Scientific, Inc.'s net margin of -47.35%. Milestone Scientific, Inc.'s return on equity of -142.42% beat Dentsply Sirona, Inc.'s return on equity of -44.58%.

Milestone Scientific, Inc. has a consensus price target of $1.00, signalling upside risk potential of 240.25%. On the other hand Dentsply Sirona, Inc. has an analysts' consensus of $12.83 which suggests that it could grow by 0.42%. Given that Milestone Scientific, Inc. has higher upside potential than Dentsply Sirona, Inc., analysts believe Milestone Scientific, Inc. is more attractive than Dentsply Sirona, Inc..

Milestone Scientific, Inc. has a beta of 0.891, which suggesting that the stock is 10.933% less volatile than S&P 500. In comparison Dentsply Sirona, Inc. has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.3%.

Milestone Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona, Inc. offers a yield of 5.01% to investors and pays a quarterly dividend of $0.16 per share. Milestone Scientific, Inc. pays -- of its earnings as a dividend. Dentsply Sirona, Inc. pays out 13.85% of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Milestone Scientific, Inc. quarterly revenues are $2.4M, which are smaller than Dentsply Sirona, Inc. quarterly revenues of $904M. Milestone Scientific, Inc.'s net income of -$1.2M is higher than Dentsply Sirona, Inc.'s net income of -$428M. Notably, Milestone Scientific, Inc.'s price-to-earnings ratio is -- while Dentsply Sirona, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Milestone Scientific, Inc. is 2.67x versus 0.70x for Dentsply Sirona, Inc.. Usually stocks with elevated PS ratios are considered overvalued.